- Home
- WLDN vs LENZ Comparison
WLDN vs LENZ Comparison
Compare WLDN & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDN
- LENZ
- Stock Information
- Founded
- WLDN 1964
- LENZ 2019
- Country
- WLDN United States
- LENZ United States
- Employees
- WLDN N/A
- LENZ N/A
- Industry
- WLDN Military/Government/Technical
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- WLDN Consumer Discretionary
- LENZ Health Care
- Exchange
- WLDN Nasdaq
- LENZ Nasdaq
- Market Cap
- WLDN 826.2M
- LENZ 886.0M
- IPO Year
- WLDN 2006
- LENZ 2021
- Fundamental
- Price
- WLDN $113.01
- LENZ $37.85
- Analyst Decision
- WLDN Strong Buy
- LENZ Strong Buy
- Analyst Count
- WLDN 3
- LENZ 4
- Target Price
- WLDN $91.33
- LENZ $49.75
- AVG Volume (30 Days)
- WLDN 481.6K
- LENZ 648.2K
- Earning Date
- WLDN 08-07-2025
- LENZ 07-30-2025
- Dividend Yield
- WLDN N/A
- LENZ N/A
- EPS Growth
- WLDN 94.22
- LENZ N/A
- EPS
- WLDN 2.39
- LENZ N/A
- Revenue
- WLDN $628,172,000.00
- LENZ $5,000,000.00
- Revenue This Year
- WLDN N/A
- LENZ N/A
- Revenue Next Year
- WLDN $9.94
- LENZ $556.26
- P/E Ratio
- WLDN $47.19
- LENZ N/A
- Revenue Growth
- WLDN 13.82
- LENZ N/A
- 52 Week Low
- WLDN $30.43
- LENZ $16.54
- 52 Week High
- WLDN $121.00
- LENZ $41.70
- Technical
- Relative Strength Index (RSI)
- WLDN 74.34
- LENZ 60.20
- Support Level
- WLDN $85.74
- LENZ $34.88
- Resistance Level
- WLDN $121.00
- LENZ $40.95
- Average True Range (ATR)
- WLDN 6.39
- LENZ 2.90
- MACD
- WLDN 2.35
- LENZ 0.84
- Stochastic Oscillator
- WLDN 82.07
- LENZ 72.32
About WLDN Willdan Group Inc.
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.